Identification of Cystatin C, a Cysteine Proteinase Inhibitor, as a Major Secretory Product of Human Alveolar MacrophagesIn Vitro
- 1 March 1990
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 141 (3) , 698-705
- https://doi.org/10.1164/ajrccm/141.3.698
Abstract
The major inhibitor of the cysteine class of proteinases found in human body fluids, such as spinal fluid, milk, and seminal plasma, is cystatin C. In this study we show that human bronchoalveolar fluid also contains cystatin C and examine cystatin C expression by alveolar macrophages in vitro. Immunoprecipitation of extracts of metabolically labeled cells and immunoblotting of cellular extracts and culture media show that cystatin C is synthesized as a 14 (.+-. 0.5) kilodalton (kD) protein and that greater than 90% of the protein is released as the 14 kD product into the culture supernatant (26.5 .+-. 6.8 ng per 106 cells per 24 h). Cystatin C is one of the most abundant proteins secreted during the first 24 h in vitro, representing .apprx. 10 to 12% of the total protein released by normal nonsmoker macrophages. Alveolar macrophages obtained from cigarette smokers or nonsmoker macrophages exposed to zymosan in vitro released 10 to 55% less cystatin C than nonsmoker macrophages. We also assayed culture supernatants from macrophages of smokers and nonsmokers for functional cystatin C. Supernatants of nonsmoker macrophages inhibited cathespin B-like amidolytic activity in a fluorometric assay at pH 5.5. The inhibition was blocked by adsorption with Sepharose-coupled cystatin C antibodies and the inhibitor subsequently recovered from the Sepharose beads. In contrast, supernatants from smoker macrophages had obvious cathespin B-like activity. Following adsorption of smoker cell supernatants with the solid-phase cystatin c antibodies, cathepsin B-like activity increased over 100%, confirming the immunoblot data indicating that smoker macrophages also release cystatin C. These data indicate that cystatin C is a major constitutive secretory product of alveolar macrophages and normally masks the activity of cysteine proteinases also secreted by these cells. During inflammatory processes, such as that produced by cigarette smoking, cystatin C release is downregulated, contributing to increased acidic proteinase activity in the macrophage microenvironment. This altered balance of enzyme and inhibitor release may contribute to the macrophage-mediated connective tissue remodeling known to be a part of inflammatory processes.This publication has 40 references indexed in Scilit:
- Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatinBiochemical Journal, 1986
- Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.Journal of Clinical Investigation, 1985
- Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.Journal of Clinical Investigation, 1984
- Biosynthesis in vitro of complement subcomponents C1q, C1s and C1̅ inhibitor by resting and stimulated human monocytesBiochemical Journal, 1983
- Biosynthesis and transport of lysosomal enzymes in human monocytes and macrophages. Effects of ammonium chloride, zymosan and tunicamycinBiochemical Journal, 1983
- Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.Proceedings of the National Academy of Sciences, 1982
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981
- [41] Cathepsin B, cathepsin H, and cathepsin LPublished by Elsevier ,1981
- Secretion of alpha-2-macroglobulin by human alveolar macrophagesLung, 1980
- Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.The Journal of Experimental Medicine, 1980